184742191	184742191	CD	B-NP	O
|	|	NN	I-NP	O
ASMH	ASMH	NN	I-NP	O
|	|	NN	I-NP	O
11101800	11101800	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9948506	9948506	CD	B-NP	O
|	|	CC	I-NP	O
10/10/2003	10/10/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
RT.	RT.	NNP	I-NP	O
.	.	.	O	O

ANKLE	ANKLE	NNP	B-NP	O
OSTEOARTHRITIS	OSTEOARTHRITIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/25/2003	8/25/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/1/2003	11/1/2003	CD	B-NP	O
Date	Date	NNP	I-NP	O
of	of	IN	B-PP	O
Discharge	Discharge	NNP	B-NP	O
:	:	:	O	O
11/1/2003	11/1/2003	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
ROD	ROD	NN	B-NP	O
GLEMBOCKI	GLEMBOCKI	NN	I-NP	O
MD	MD	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Right	Right	NN	B-NP	O
ankle	ankle	NN	I-NP	O
fusion	fusion	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
ankle	ankle	NN	I-NP	O
fusion	fusion	NN	I-NP	O
and	and	CC	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Cleared	Cleared	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
transplant	transplant	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
osteoporosis	osteoporosis	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65-year-old	65-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
endocarditis	endocarditis	NN	B-NP	O
ultimately	ultimately	RB	B-VP	O
requiring	require	VBG	I-VP	O
heart	heart	NN	B-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
diabetes	diabete	VBZ	B-VP	O
mellitus	mellitus	NN	B-NP	O
type	type	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
fusion	fusion	NN	I-NP	O
.	.	.	O	O

About	About	IN	B-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
fell	fall	VBD	B-VP	O
down	down	RP	B-PRT	O
stairs	stair	NNS	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
pilon	pilon	NN	I-NP	O
fracture	fracture	NN	I-NP	O
initially	initially	RB	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
cast	cast	NN	B-NP	O
immobilization	immobilization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
leg	leg	NN	I-NP	O
and	and	CC	I-NP	O
ankle	ankle	NN	I-NP	O
deformity	deformity	NN	I-NP	O
and	and	CC	O	O
daily	daily	RB	B-VP	O
aching	ache	VBG	I-VP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
decided	decide	VBD	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
elective	elective	JJ	I-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
fusion	fusion	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
surgery	surgery	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
vitals	vital	NNS	I-NP	O
were	be	VBD	B-VP	O
100.3	100.3	CD	B-NP	O
,	,	,	I-NP	O
111	111	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
upon	upon	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
face	face	NN	I-NP	O
mask	mask	NN	I-NP	O
.	.	.	O	O

Exam	Exam	NNP	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
with	with	IN	B-PP	O
wheezing	wheeze	VBG	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
S4	S4	NN	I-NP	I-protein
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
with	with	IN	B-PP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
cyclosporin	cyclosporin	NN	B-NP	O
levels	level	NNS	I-NP	O
133	133	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
diuresis	diuresis	NN	I-NP	O
for	for	IN	B-PP	O
proper	proper	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
4	4	CD	B-NP	O
L	L	NN	I-NP	O
intraoperatively	intraoperatively	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
developed	develop	VBD	B-VP	O
low-grade	low-grade	JJ	B-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
102	102	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
left	leave	VBN	I-VP	O
calf	calf	NN	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
spiral	spiral	JJ	I-NP	B-DNA
CT	CT	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
BUN	BUN	NN	I-NP	O
to	to	TO	B-PP	O
creatinine	creatinine	NN	B-NP	O
ratio	ratio	NN	I-NP	O
trended	trend	VBD	B-VP	O
upwards	upwards	RB	B-ADVP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
31/2	31/2	CD	I-NP	O
.3	.3	CD	I-NP	O
from	from	IN	B-PP	O
29/1	29/1	CD	B-NP	O
.7	.7	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
cardiology	cardiology	NN	B-NP	O
3	3	CD	I-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
developing	develop	VBG	B-VP	O
hypertension	hypertension	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
,	,	,	O	O
systolic	systolic	JJ	B-ADJP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
105	105	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
cardiology	cardiology	NN	B-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vitals	vital	NNS	I-NP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
were	be	VBD	B-VP	O
T	T	NN	B-NP	O
max	max	NN	I-NP	O
100.4	100.4	CD	B-NP	O
to	to	TO	B-PP	O
current	current	NN	B-NP	O
99.2	99.2	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
99	99	CD	I-NP	O
to	to	TO	B-PP	O
108	108	CD	B-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
99	99	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
ranging	range	VBG	I-VP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
to	to	TO	B-PP	O
102	102	CD	B-NP	O
over	over	IN	B-PP	O
doppler	doppler	NN	B-NP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
,	,	,	O	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
high	high	JJ	B-NP	O
flow	flow	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
bibasilar	bibasilar	JJ	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
and	and	CC	O	O
tachycardia	tachycardia	NNS	B-NP	O
around	around	IN	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
with	with	IN	B-PP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
only	only	RB	B-NP	O
6.5	6.5	CD	I-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
of	of	IN	B-PP	O
4.1	4.1	CD	B-NP	O
from	from	IN	B-PP	O
2.3	2.3	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
41	41	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
portable	portable	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
with	with	IN	B-PP	O
focal	focal	JJ	B-NP	O
opacity	opacity	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lung	lung	NN	I-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
97	97	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
Q	Q	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	O
and	and	CC	I-NP	O
V3	V3	NN	I-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
RSR	RSR	NN	B-NP	B-protein
prime	prime	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

V1	V1	NN	B-NP	B-protein
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
RS	RS	NN	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
milliseconds	millisecond	NNS	I-NP	O
,	,	,	O	O
not	not	RB	O	O
significantly	significantly	RB	B-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NNP	B-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
shown	show	VBN	I-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
and	and	CC	O	O
preserved	preserve	VBN	B-VP	O
systolic	systolic	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
posterior	posterior	JJ	I-NP	O
and	and	CC	I-NP	O
lateral	lateral	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
valves	valve	NNS	I-NP	O
mildly	mildly	RB	B-VP	O
thickened	thicken	VBN	I-VP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
MR.	MR.	NNP	I-NP	O
Stress	Stress	NNP	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
2003	2003	CD	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
protocol	protocol	NN	I-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
2003	2003	CD	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
,	,	,	O	O
PCWP	PCWP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
28	28	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d	q.d	NN	I-NP	O
,	,	,	O	O
The	The	DT	B-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
rejection	rejection	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
diabetes	diabete	VBZ	B-VP	O
mellitus	mellitus	NN	B-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
GERD	GERD	NNP	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1985	1985	CD	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
septic	septic	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
with	with	IN	B-PP	O
brain	brain	NN	B-NP	O
abscess	abscess	NN	I-NP	O
postoperative	postoperative	JJ	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
MVR	MVR	NN	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
,	,	,	O	O
osteoporosis	osteoporosis	NN	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

OUTPATIENT	OUTPATIENT	JJ	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Mag	Mag	NN	B-NP	O
oxide	oxide	NN	I-NP	O
,	,	,	O	O
Tums	Tums	NNP	B-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
,	,	,	O	O
Lexapro	Lexapro	NNP	B-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
Cyclosporin	Cyclosporin	NN	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
Imuran	Imuran	NNP	B-NP	O
,	,	,	O	O
Cozaar	Cozaar	NNP	B-NP	O
,	,	,	O	O
Cardizem	Cardizem	NNP	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Nephrox	Nephrox	NN	B-NP	O
,	,	,	O	O
Pravachol	Pravachol	NN	B-NP	O
,	,	,	O	O
Fosamax	Fosamax	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
60	60	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	NN	B-NP	I-protein
10	10	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.p.m.	q.p.m.	NN	I-NP	I-protein
ALLERGIES	ALLERGIES	NN	I-NP	I-protein
:	:	:	O	I-protein
Penicillin	Penicillin	NN	B-NP	I-protein
causes	cause	VBZ	B-VP	O
rash	rash	NN	B-NP	O
,	,	,	O	O
codeine	codeine	NN	B-NP	O
causes	cause	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Quit	Quit	NNP	B-NP	O
smoking	smoking	NN	I-NP	O
in	in	IN	B-PP	O
1978	1978	CD	B-NP	O
,	,	,	O	O
rare	rare	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
IV	IV	CD	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
vitals	vital	NNS	B-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
84	84	CD	I-NP	O
%	%	NN	I-NP	O
range	range	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
operation	operation	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
cast	cast	NN	I-NP	O
placed	place	VBN	B-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
team	team	NN	I-NP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
consulting	consulting	NN	I-NP	O
team	team	NN	I-NP	O
,	,	,	O	O
once	once	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
medicine	medicine	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
her	her	PRP$	B-NP	O
toes	toe	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
splint	splint	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
complications	complication	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rutecki	Rutecki	NNP	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
worked	work	VBD	B-VP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
to	to	TO	B-PP	O
peripheral	peripheral	JJ	B-NP	O
functional	functional	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
3	3	CD	I-NP	O
to	to	TO	I-NP	O
5	5	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
motion	motion	NN	I-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
strength	strength	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
prevents	prevent	VBZ	B-VP	O
her	her	PRP	B-NP	O
from	from	IN	B-PP	O
performing	perform	VBG	B-VP	O
NWB	NWB	NN	B-NP	B-protein
gait	gait	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADVP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overloaded	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
euvolemic	euvolemic	JJ	I-ADJP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
hypotension	hypotension	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
elevated	elevate	VBD	B-VP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
filling	filling	NN	I-NP	O
pressure	pressure	NN	I-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
that	that	WDT	B-NP	O
also	also	RB	B-ADVP	O
revealed	reveal	VBD	B-VP	O
fluid	fluid	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fissure	fissure	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
poor	poor	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Lasix	Lasix	NNP	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
sepsis	sepsis	NN	I-NP	O
because	because	IN	B-SBAR	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
drop	drop	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
60	60	CD	I-NP	O
and	and	CC	I-NP	O
70	70	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
and	and	CC	I-NP	O
required	require	VBN	I-NP	O
Dopamine	Dopamine	NN	I-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

Once	Once	RB	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
,	,	,	O	O
a	a	DT	B-NP	O
Swan-Ganz	Swan-Ganz	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
SVR	SVR	NN	B-NP	B-protein
of	of	IN	B-PP	O
689	689	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
of	of	IN	B-PP	O
5.8	5.8	CD	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
were	be	VBD	B-VP	O
high	high	JJ	B-ADJP	O
also	also	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
response	response	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
and	and	CC	O	O
then	then	RB	O	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
team	team	NN	I-NP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

For	For	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
Pravachol	Pravachol	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
ischemic	ischemic	JJ	I-NP	I-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
including	include	VBG	B-PP	O
diabetes	diabete	NNS	B-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
she	she	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
remained	remain	VBD	B-VP	O
good	good	JJ	B-ADJP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	I-VP	O
post	post	VB	I-VP	O
ATN	ATN	NN	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
ins	in	NNS	I-NP	O
and	and	CC	I-NP	O
outs	out	NNS	I-NP	O
remained	remain	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
prednisone	prednisone	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	RB	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Imuran	Imuran	NNP	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
chest	ch	JJS	I-NP	O
x-ray	x-ray	NN	I-NP	O
findings	finding	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
broad	broad	JJ	B-NP	O
covers	cover	NNS	I-NP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
azithromycin	azithromycin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

All	All	PDT	B-NP	O
the	the	DT	I-NP	O
blood	blood	NN	I-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
presumed	presume	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
Ceptaz	Ceptaz	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RP	B-PRT	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
with	with	IN	B-PP	O
only	only	RB	B-NP	O
faint	faint	JJ	I-NP	O
inspiratory	inspiratory	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
MRSA	MRSA	NN	I-NP	B-protein
nares	nare	VBZ	B-VP	O
cultures	culture	NNS	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
one	one	CD	I-NP	O
was	be	VBD	B-VP	O
pending	pende	VBG	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
sputum	sputum	NN	B-NP	O
Gram	Gram	NN	I-NP	O
stain	stain	NN	I-NP	O
and	and	CC	I-NP	O
culture	culture	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
rose	rise	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
was	be	VBD	B-VP	O
multifactorial	multifactorial	JJ	B-ADJP	O
including	include	VBG	B-PP	O
dye	dye	NN	B-NP	O
load	load	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	B-protein
,	,	,	O	O
spiral	spiral	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
likely	likely	RB	B-ADJP	O
from	from	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
renal	renal	JJ	B-NP	O
consult	consult	NN	I-NP	O
and	and	CC	B-PP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
improved	improve	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
baseline	baseline	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
interim	interim	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Sevelamer	Sevelamer	NNP	B-NP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
phosphorus	phosphorus	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
phosphorus	phosphorus	NN	I-NP	O
level	level	NN	I-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
,	,	,	O	O
Lactulose	Lactulose	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
report	report	VB	I-VP	O
any	any	DT	B-NP	O
GI	GI	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

Hematology	Hematology	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
subcu	subcu	NN	B-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
and	and	CC	I-NP	O
Niferex	Niferex	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
During	During	IN	B-PP	O
the	the	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
test	test	NN	B-NP	O
dose	dose	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
with	with	IN	B-PP	O
hydrocortisone	hydrocortisone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hydrocortisone	hydrocortisone	NN	I-NP	O
was	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
placed	place	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
prednisone	prednisone	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	B-DNA
home	home	NN	I-NP	I-DNA
NPH	NPH	NN	I-NP	I-DNA
60	60	CD	B-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
develop	develop	VB	I-VP	O
some	some	DT	B-NP	O
hypoglycemic	hypoglycemic	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
37	37	CD	B-NP	O
,	,	,	O	O
so	so	IN	O	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
breathing	breathe	VBG	I-VP	O
comfortably	comfortably	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Neurology	Neurology	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
waxing	waxing	NN	I-NP	O
and	and	CC	I-NP	O
waning	waning	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
and	and	CC	I-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
slowed	slow	VBD	B-VP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
questioning	question	VBG	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
markedly	markedly	RB	B-ADJP	O
slower	slow	JJR	I-ADJP	O
to	to	TO	B-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
questioning	question	VBG	B-VP	O
but	but	CC	O	O
normally	normally	RB	B-VP	O
oriented	orient	VBN	I-VP	O
to	to	TO	B-PP	O
place	place	NN	B-NP	O
and	and	CC	I-NP	O
person	person	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
as	as	IN	B-SBAR	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
at	at	IN	B-PP	O
bedside	bedside	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Imuran	Imuran	NNP	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Heparin	Heparin	NN	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
human	human	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
60	60	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcu	subcu	NN	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
NPH	NPH	NN	I-NP	I-protein
human	human	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
40	40	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcu	subcu	NN	I-NP	I-protein
q.p.m.	q.p.m.	NN	I-NP	I-protein
regular	regular	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcu	subcu	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
Lactulose	Lactulose	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Nystatin	Nystatin	NN	B-NP	O
cream	cream	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Pravachol	Pravachol	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
cyclosporin	cyclosporin	NN	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Diltiazem	Diltiazem	NNP	B-NP	O
Extended	Extended	NNP	I-NP	O
Release	Release	NNP	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Miconazole	Miconazole	NN	B-NP	O
Nitrate	Nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Magnesium	Magnesium	NNP	B-NP	O
oxide	oxide	NN	I-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
,	,	,	O	O
p.r.n.	p.r.n.	NN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
Lexapro	Lexapro	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Fosamax	Fosamax	NN	B-NP	O
70	70	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
orthopedics	orthopedic	NNS	B-NP	O
Dr.	Dr.	NNP	B-NP	O
Hodnett	Hodnett	NNP	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
3	3	CD	B-NP	O
to	to	TO	I-NP	O
5	5	CD	I-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
her	her	PRP$	B-NP	O
mobility	mobility	NN	I-NP	O
and	and	CC	I-NP	O
functional	functional	JJ	I-NP	O
status	status	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
recommendations	recommendation	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

Please	Please	NNP	B-NP	O
call	call	NN	I-NP	O
Lecer	Lecer	NNP	I-NP	O
Nigein	Nigein	NNP	I-NP	O
Sotarnock	Sotarnock	NNP	I-NP	O
University	University	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
or	or	CC	O	O
look	look	VB	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
records	record	NNS	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
what	what	WP	B-NP	O
her	her	PRP$	B-NP	O
third	third	JJ	I-NP	O
MRSA	MRSA	NN	I-NP	O
culture	culture	NN	I-NP	O
report	report	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-SBAR	O
nares	nare	NNS	B-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
3	3	CD	B-NP	O
negative	negative	JJ	I-NP	O
MRSA	MRSA	NN	I-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O
precautions	precaution	NNS	I-NP	O
any	any	DT	B-ADVP	O
longer	longer	RBR	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
service	service	NN	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
weeks	week	NNS	I-NP	O
at	at	IN	B-PP	O
Pen	Pen	NNP	B-NP	O
Broadl	Broadl	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-2471886	9-2471886	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Carl	Carl	NNP	B-NP	O
Vicic	Vicic	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Thasstown	Thasstown	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
S	S	NNP	I-NP	O
Clark	Clark	NNP	I-NP	O
Li	Li	NNP	I-NP	O
Hensherbhope	Hensherbhope	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
,	,	,	O	O
Na	Na	NNP	B-NP	O
Pendlos	Pendlos	NNP	I-NP	O
La	La	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Ricardo	Ricardo	NNP	B-NP	O
Mordue	Mordue	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Mondfull	Mondfull	NNP	I-NP	O
Call	Call	NNP	I-NP	O
Rangesnohisa	Rangesnohisa	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Craig	Craig	NNP	B-NP	O
Aitkin	Aitkin	NNP	I-NP	O
Rance	Rance	NNP	I-NP	O
Vei	Vei	NNP	I-NP	O
Naren	Naren	NNP	I-NP	O
Chale	Chale	NNP	I-NP	O
Rd.	Rd.	NNP	I-NP	O
,	,	,	O	O
Sto	Sto	NNP	B-NP	O
Woodjose	Woodjose	NNP	I-NP	O
A	A	NNP	I-NP	O
,	,	,	O	O
New	New	NNP	B-NP	O
York	York	NNP	I-NP	O
47813	47813	CD	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MAKAREM	MAKAREM	NN	B-NP	O
,	,	,	O	O
CORNELIUS	CORNELIUS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
RYZINSKI	RYZINSKI	NN	B-NP	O
,	,	,	O	O
OSCAR	OSCAR	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9539323	9539323	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/7/03	4/7/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/7/03	4/7/03	CD	B-NP	O

